Lucera Erick (CIK 1697616) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-17). Recent activity: Sell DYN (1,797 shares), Sell DYN (2,362 shares), Sell DYN (1,448 shares), Sell DYN (5,727 shares), Buy DYN (65,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Sell | 1,797 | $47,225 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Sell | 2,362 | $48,114 |
| 2026-05-14 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Sell | 1,448 | $26,585 |
| 2026-04-03 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Sell | 5,727 | $106,751 |
| 2026-02-17 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Buy | 65,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-17